Lethal Strongyloides stercoralis superinfection in an immunocompromised patient

Renal Failure

Volumn 32, Issue 6, 2010, Pages 750-752

  Kosmadakis, George ^a   Georgoulias, Christodoulos ^a   Filiopoulos, Vasileios ^a   Stefanou, Ioanna ^a   Smirloglou, Despoina ^a   Michail, Spyridon ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Hemodialysis; Hyperinfection; Immunosuppression; Parasitic infections; Strongyloides stercoralis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; METRONIDAZOLE; PREDNISOLONE; THIOPENTAL; THYROID HORMONE; VANCOMYCIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHEST INFECTION; DIABETES MELLITUS; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHILIA; FATALITY; FEVER; HEART ARREST; HEART INFARCTION; HEMATURIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOPTYSIS; HOSPITAL INFECTION; HUMAN; HYPERTENSION; IMMUNOCOMPROMISED PATIENT; INTUBATION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LERICHE SYNDROME; MALE; NEUTROPENIA; NEUTROPHIL; NEUTROPHILIA; NORMOCHROMIC NORMOCYTIC ANEMIA; PRIORITY JOURNAL; RESUSCITATION; SOLITARY KIDNEY; SPUTUM ANALYSIS; SPUTUM CULTURE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION; TACHYPNEA; VASCULITIS;

ANIMALS; FATAL OUTCOME; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION;

EID: 77953573218     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.486490     Document Type: Article

References (21)

1. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007;41(12):1992-2001.
2. Genta RM. Global prevalence of strongyloidiasis: Critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11:755-767.
3. Robson D, Welch E, Beeching NJ, Gill GV. Consequences of captivity: Health effects of far East imprisonment in World War II. QJM. 2009;102(2):87-96.
4. Gill GV, Beeching NJ, Khoo S, et al.. A British Second World War veteran with disseminated strongyloidiasis. Trans R Soc Trop Med Hyg. 2004;98(6):382-386.
5. Liu LX, Weller PF: Strongyloidiasis and other nematode infections. Infect Dis Clin North Am. 1993;7:655-682.
6. Concha R, Harrington W, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcomes. J Clin Gastroenterol. 2005;39:203-211.
7. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208-217.
8. Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KVI. Strongyloidiasis in patients at a comprehensive cancer center in the United States: A retrospective study covering the years 1971-2003. Cancer. 2004;100:1531-1536.
9. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC. Complicated and fatal Strongyloides infection in Canadians: Risk factors, diagnosis and management. CMAJ. 2004;171:479-484.
10. Lam CS, Tong MKH, Chan KM, Siu YP. Disseminated strongyloidiasis: A retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis. 2006;25:14-18.
11. Zaha O, Hirata T, Kinjo F, Saito A. Strongyloidiasis - Progress in diagnosis and treatment. Intern Med. 2000;39:695-700.
12. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001;33:1040-1047.
13. Igual-Adeli R, Oltra-Alcaraz C, Soler-Company E, Sánchez- Sánchez P, Matogo-Oyana J, Rodríguez-Calabuig D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin Pharmacother. 2004;5:2615-2619.
14. Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, Takara M. Comparative studies on the efficacy of three antihelminthics on treatment of human strongyloidiasis. Southeast Asian J Trop Med Public Health. 2000;31(1):147-151.
15. Morrell MR, Dallas J, Kollef MHA 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantation. Chest. 2008;134(2):442-446.
16. Soman R, Vaideeswar P, Shah H, Almeida AFA 34-year-old renal transplant recipient with high-grade fever and progressive shortness of breath. J Postgrad Med. 2002;48(3):191-196.
17. Miyazaki M, Tamura M, Kabashima N, et al.. Minimal change nephrotic syndrome in a patient with strongyloidiasis. Clin Exp Nephrol. 2010;Mar 12.
18. Rajapurkar M, Hegde U, Rokhade M, Gang S, Gohel K. Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure. Nat Clin Pract Nephrol. 2007;3(10):573-577.
19. Hsieh YP, Wen YK, Chen ML. Minimal change nephrotic syndrome in association with strongyloidiasis. Clin Nephrol. 2006;66(6):459-463.
20. Mori S, Konishi T, Matsuoka K, et al.. Strongyloidiasis associated with nephrotic syndrome. Intern Med. 1998;37(7):606-610.
21. Liepman M. Disseminated Strongyloides stercoralis. A complication of immunosuppression. JAMA. 1975;231(4):387-388.